Cargando…

Evidence of the association between adherence to treatment and mortality among patients with COPD monitored at a public disease management program in Brazil

OBJECTIVE: To evaluate the association between adherence to treatment and mortality among Chronic Obstructive Pulmonary Disease (COPD) patients treated in the Brazilian public health system. METHODS: This is cohort study of moderate-to-severe COPD patients monitored in a public pharmaceutical care-b...

Descripción completa

Detalles Bibliográficos
Autores principales: de Moreira, Aramís Tupiná Alcantara, Pinto, Charleston Ribeiro, Lemos, Antônio Carlos Moreira, Assunção-Costa, Lindemberg, Souza, Gisélia Santana, Martins, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946558/
https://www.ncbi.nlm.nih.gov/pubmed/34909924
http://dx.doi.org/10.36416/1806-3756/e20210120
Descripción
Sumario:OBJECTIVE: To evaluate the association between adherence to treatment and mortality among Chronic Obstructive Pulmonary Disease (COPD) patients treated in the Brazilian public health system. METHODS: This is cohort study of moderate-to-severe COPD patients monitored in a public pharmaceutical care-based Disease Management Program (DMP). All subjects who died one year after the beginning of the cohort were age-matched with those who remained alive at the end of the cohort period. Treatment adherence was measured through pharmacy records. Patients who received at least 90% of the prescribed doses were considered adherent to treatment. RESULTS: Of the 333 patients (52.8% age ≥ 65 years, 67.9% male), 67.3% were adherent to treatment (adherence rate, 87.2%). Mortality was associated with lack of adherence (p = 0.04), presence of symptoms (mMRC ≥ 2) and COPD treatment use. The death was associated with non-adherence, presence of symptoms and previous hospitalization. After adjustment, non-adherent patients to treatment were almost twice times likely to die compared to those adherents (Hazard Ratio (HR) 1.86; CI 1.16-2.98, p = 0.01). CONCLUSION: Non-adherence to treatment was associated with higher mortality among moderate-to-severe COPD patients treated in the Brazilian public health system. Strategies to monitor and optimize adherence should be strengthened to reduce COPD-related mortality.